Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-31

Clinical Trial Update: Effect of Gelofusine on GLP1-receptor Imaging [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/Phase 2 trial evaluating the effect of Gelofusine on GLP-1 receptor imaging in individuals with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gelofusine

Snippet

Sponsor: Radboud University Medical Center | Conditions: Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED